Evidence map›Paper›PMID 36744246›Full record

ArticleFrontiers in pharmacology2023

Polydopamine-based loaded temozolomide nanoparticles conjugated by peptide-1 for glioblastoma chemotherapy and photothermal therapy.

Hao Wu, Tianyi Zhang, Qi Liu, Min Wei, Yuping Li, Qiang Ma, Lianhui Wang, Yufu Zhu, Hengzhu Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Nanotherapy of Glioblastoma-Where Hope Grows.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Nanoparticles-Mediated Modulation of TRP Channels: Advances and Therapeutic Potential.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Hao WuGraduate School of Dalian Medical University, Dalian, China.
Tianyi ZhangNanjing University, Nanjing, China.
Qi LiuDepartment of Neurosurgery, The First Hospital of Yu Lin, Yulin, China.
Min WeiGraduate School of Dalian Medical University, Dalian, China.
Yuping LiDepartment of Neurosurgery, Clinical Medical College, Yangzhou University, Yangzhou, China.
Qiang MaDepartment of Neurosurgery, Clinical Medical College, Yangzhou University, Yangzhou, China.
Lianhui WangInstitute of Advanced Materials, Nanjing University of Posts and Telecommunications, Nanjing, China.
Yufu ZhuDepartment of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Hengzhu ZhangDepartment of Neurosurgery, Clinical Medical College, Yangzhou University, Yangzhou, China.
Yangzhou University · CNNanjing University · CNNanjing University of Posts and Telecommunications · CNXuzhou Medical College · CNYulin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemo/photothermal therapyglioblastomananoparticlesPEP-1polydopaminetemozolomide

Identifiers

PMID36744246
PMCPMC9889548
OpenAlexW4317397660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.